Axio Research competitors

Zippia score 3.8

Axio Research main competitors are Vertex Pharmaceuticals, Parexel International, and U.S. Pharmacopeia.

Competitor Summary. See how Axio Research compares to its main competitors:

Parexel International has the most employees (18,900).
Employees at Vertex Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $95,952.
The oldest company is U.S. Pharmacopeia, founded in 1820.

Work at Axio Research?

Share your experience

Axio Research vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Axio Research	1979	3.8	Seattle, WA	1	$5.4M	50
Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$11.0B	3,400
Achillion Pharmaceuticals	1998	3.8	New Haven, CT	1	$15.0M	56
Medpace	1992	4.5	Cincinnati, OH	3	$2.1B	2,800
Biopharma	1896	4.1	-	-	$200,000	500
BASi	1974	4.0	West Lafayette, IN	3	$23.5M	421
Biocon	2003	4.3	Edison, NJ	2	$590.0M	9,234
Pharmaceutical Research Associates, Inc.	1981	4.6	Reston, VA	1	$30.0M	30
Critical Path Institute	2005	4.4	Tucson, AZ	1	$10.0M	25
Parexel International	1983	4.5	Waltham, MA	9	$2.4B	18,900
U.S. Pharmacopeia	1820	4.8	Rockville, MD	4	$170.0M	750
Clinical Data	2007	4.5	Newton, MA	1	-	160
Novella	1998	4.2	Morrisville, NC	1	$9.2M	3,000

Rate how well Axio Research differentiates itself from its competitors.

Axio Research salaries vs competitors

Among Axio Research competitors, employees at Vertex Pharmaceuticals earn the most with an average yearly salary of $95,952.

Compare Axio Research salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Axio Research	$75,972	$36.52	-
Vertex Pharmaceuticals	$95,952	$46.13	-
Achillion Pharmaceuticals	$75,385	$36.24	-
Medpace	$69,547	$33.44	-
Biopharma	$69,292	$33.31	-
BASi	$75,192	$36.15	-

Compare Axio Research job title salaries vs competitors

Company	Highest salary	Hourly salary
Axio Research	$96,696	$46.49
Vertex Pharmaceuticals	$116,184	$55.86
U.S. Pharmacopeia	$103,358	$49.69
BASi	$101,612	$48.85
Parexel International	$98,693	$47.45
Pharmaceutical Research Associates, Inc.	$97,202	$46.73
Biocon	$96,322	$46.31
Achillion Pharmaceuticals	$96,036	$46.17
Clinical Data	$95,970	$46.14
Novella	$95,662	$45.99
Medpace	$92,394	$44.42
Biopharma	$91,423	$43.95
Critical Path Institute	$89,105	$42.84

Do you work at Axio Research?

Is Axio Research able to compete effectively with similar companies?

Axio Research jobs

Axio Research demographics vs competitors

Compare gender at Axio Research vs competitors

Job title	Male	Female
Medpace	33%	67%
Parexel International	40%	60%
BASi	47%	53%
Achillion Pharmaceuticals	50%	50%
Vertex Pharmaceuticals	56%	44%
Axio Research	-	-

Male

Female

100%

75%

50%

25%

Axio Research

Vertex Pharmaceuticals

Achillion Pharmaceuticals

BASi

Parexel International

Medpace

25%

50%

75%

100%

Compare race at Axio Research vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Achillion Pharmaceuticals	61%	13%	6%	17%	2%	6.4
BASi	67%	10%	11%	9%	3%	7.4
Medpace	66%	11%	8%	12%	3%	9.5
Parexel International	57%	13%	11%	15%	5%	9.8
Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7
Biocon	26%	8%	7%	56%	4%	8.9

Axio Research and similar companies CEOs

CEOBio

Milind Deshpande

Achillion Pharmaceuticals

Milind Deshpande is a President and Chief Executive Officer at ACHILLION PHARMACEUTICALS INC and is based in United States.

Brian R. Bond

BASi

August J. Troendle M.D.

Medpace

August Troendle is a Chairman/President/CEO/Founder at Medpace and is based in Ohio. He has worked as Board Member at Xenon Pharmaceuticals Inc. and Board Member at COHERUS BIOSCIENCES, INC.. August studied at University of Maryland.

Jamie MacDonald

Parexel International

Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies. Prior to joining Parexel, Mr. Macdonald served as CEO of INC Research, now known as Syneos Health, from January 2013 through September 2016, where he led the company through a successful Initial Public Offering in 2014. Mr. Macdonald also served as INC’s Chief Operating Officer from July 2011 through December 2012, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this, he held various senior operational and finance roles at Quintiles. He has previously served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and as its Chairman in 2015. Mr. Macdonald’s recent experience also includes serving as Chairman of the Board for Certara, a drug development consultancy with solutions spanning discovery, preclinical and clinical drug development, from 2017 to 2018. Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Richard Staub

Novella

Ronald T. Piervincenzi

U.S. Pharmacopeia

Ronald Piervincenzi is a Chief Executive Officer at United States Pharmacopeia and is based in Rockville, Maryland. He has worked as Principal at McKinsey & Company and VP Development Sciences Business Strategy at BIOGEN INC.. Ronald studied at Hofstra University between 1989 and 1993 and Duke University between 1993 and 2000.

Andrew J. Fromkin

Clinical Data

Andrew J. Fromkin is a President and CEO at Clinical Data Inc.